The phospho-NDRG1 (Ser330) cellular assay kit enables the cell-based quantitative detection of phosphorylated NDRG1 at Ser330.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 16 µL |
The phospho-NDRG1 (Ser330) cellular assay kit enables the cell-based quantitative detection of phosphorylated NDRG1 at Ser330.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
The Phospho-NDRG1 (Ser330) cellular assay kit is optimal for measuring phosphorylated NDRG1 at Ser330, and is a powerful tool for cancer research. NDRG1 is upregulated by HIF1-alpha under hypoxic conditions often associated with aggressive tumor progression. NDRG1 is a metastasis suppressor that works by blocking the angiogenesis signaling pathway.
Application |
Cell Signaling
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Lysis Buffer Compatibility |
Lysis Buffer 4
Lysis Buffer 5
|
Molecular Modification |
Phosphorylation
|
Product Group |
Kit
|
Sample Volume |
16 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Phosphoproteins
|
Technology |
TR-FRET
|
Therapeutic Area |
Oncology & Inflammation
|
Unit Size |
500 Assay Points
|
The Phospho-NDRG1 (Ser330) assay measures NDRG1 when phosphorylated at Ser330. Contrary to Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer. The Phospho-NDRG1 (Ser330) assay uses 2 labeled antibodies: one with a donor fluorophore, the other one with an acceptor. The first antibody is selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the proteins phosphorylation state under a no-wash assay format.
The 2 plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a 384-well low volume detection plate before adding Phospho-NDRG1 (Ser330) HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.
Detection of Phosphorylated NDRG1 (Ser330) with HTRF reagents can be performed in a single plate used for culturing, stimulation and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
Different cell densities (100K, 50K, 25K and 12.5K) of HeLa cells were plated under 50µL in 96-well plate in presence of 40 µM of Dp44mT and incubated for 24h. Then, media was aspirated and cells were lysed with 50µL of lysis buffer 1X for 30 min at RT under gentle shaking. 16 µL of lysate were transferred into a 384-well sv white microplate and 4 µL of the HTRF phospho NDRG1 (Ser330) detection reagents were added. The HTRF signal was recorded after a overnight incubation at room temperature.
Are you looking for resources, click on the resource type to explore further.
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.